NCT03504696View on ClinicalTrials.gov

Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

December 20, 2016

Primary Completion Date

February 20, 2018

Study Completion Date

February 20, 2018

Conditions
Melanoma
Interventions
OTHER

Non-interventional

Non-interventional

Trial Locations (1)

44093

Local Institution, Nantes

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY